shot-button
Maharashtra Elections 2024 Maharashtra Elections 2024
Home > News > India News > Article > Rajesh Tope seeks increase in Remdesivir production reduction in price

Rajesh Tope seeks increase in Remdesivir production, reduction in price

Updated on: 13 April,2021 12:00 AM IST  |  Jalna
ANI |

"Companies manufacturing anti-viral drug Remdesivir should double the production and decrease its Maximum Retail Price (MRPs) to Rs 1200- Rs 1300," he said

Rajesh Tope seeks increase in Remdesivir production, reduction in price

A vial of Remdesivir. Pic/ AFP

Maharashtra Health Minister Rajesh Tope has stated that the price of anti-viral drug Remdesivir, which is also used in the treatment of COVID-19, should be reduced to Rs 1,200-Rs 1,300. He also said that companies manufacturing the anti-viral drug should double the production.


The Minister said that companies that produce Remdesivir should also double their production.


Speaking to the media he said, "Companies manufacturing anti-viral drug Remdesivir should double the production and decrease its Maximum Retail Price (MRPs) to Rs 1200- Rs 1300."


Remdisivir is reportedly being sold between Rs 2,400-6,000. The injection is being sold in black market at even higher prices.

Tope had earlier said that the state has been consuming 50,000 doses of Remdesivir on a daily basis and that it needed a much higher number of doses.

The state has been facing a shortage of Remdesivir amid a surge in cases. To tackle the shortage, the state government had decided to set up district-level control rooms to ensure a smooth supply of these injections and prevent hoarding and black-marketing of the drug.

Maharashtra reported 51,751 new COVID-19 cases and 258 deaths in the last 24 hours, the state health department informed on Monday evening.

According to the state health department, 52,312 people have recovered from the disease. The active number of cases in the state stands at 5,64,746, while the death toll has gone up to 58,245.

Notably, the Centre government on Sunday (April 11) prohibited exports of injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) till the Covid-19 situation in the country improves.

This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever.

"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!


Mid-Day Web Stories

Mid-Day Web Stories

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK